Skip to Main Content
An official website of the United States government
Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, February 14th from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime.

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
641-660 of 2645
Name Principal Investigator Institution Study Date Approved Project ID
Treatment effect in a proportional hazards model with instrumental variables lorenzo tedesco KU LEUVEN HIPB Dec 5, 2022 HIPB-10
Sedentary Behavior Patterns: A Latent Class Trajectory Analysis of Within-Day SB Patterns Margaret Damare The University of North Carolina at Chapel Hill IDATA Dec 5, 2022 IDATA-60
Association between temporal dietary patterns and sedentary behaviors in middle-aged and older adults Zain Anderson University of North Carolina Chapel Hill IDATA Dec 5, 2022 IDATA-59
A further look into the PLCO data with open questions on PSA, active surveillance, and risk factors in prostate cancer Yulong Gu Stockton University PLCO Dec 5, 2022 PLCO-1118
Dataset Analysis for Identifying General Data Statistics Jonathan Hubermann Concordia University PLCO Dec 5, 2022 PLCO-1119
Data Integration and Imputation Across Multiple Medical Datasets Vivatchai Kaveeta Chiang Mai University PLCO Dec 5, 2022 PLCO-1120
Data Science Project: To develop prediction model for Lung Cancer Risk Ella Buzhor Holon Institute of Technology (HIT) PLCO Dec 5, 2022 PLCO-1121
Machine Learning Model to Predict Various Types of Cancer Bence Lukacsy Barrington High School PLCO Dec 5, 2022 PLCO-1112
AI-based Bladder cancer risk stratification. Okyaz Eminaga Okyaz Eminaga PLCO Nov 28, 2022 PLCOI-1110
Weakly-supervised learning to develop an AI-based risk-stratification of PLCO cancers Okyaz Eminaga Okyaz Eminaga PLCO Nov 28, 2022 PLCOI-1111
Investigating polygenic prediction of cancer risk and cancer-related phenotypes Gil McVean Genomics plc PLCO Nov 22, 2022 PLCO-1106
Associations of healthy lifestyle with life expectancy and cancer free life expectancy Eleanor Watts National Cancer Institute PLCO Nov 21, 2022 PLCO-1100
Greenspace, noise pollution, and cancer risk in the PLCO cohort Rena Jones National Cancer Institute PLCO Nov 21, 2022 PLCO-1105
Mathematical modeling of biomarker dynamics in cancer patients Frederick Adler University of Utah PLCO Nov 14, 2022 PLCO-1099
Risk Factors of Prostate Cancer - A Statistical Analysis Francesco Patrucco Humanitas University PLCO Nov 9, 2022 PLCO-1098
Machine Learning Model to Predict Colorectal Cancer Bence Lukacsy Barrington High School PLCO Nov 9, 2022 PLCO-1097
Clarifying Lung Cancer Risk Among Breast Cancer Survivors Keith Sigel The Mount Sinai Hospital PLCO Nov 9, 2022 PLCO-1092
What does the National Lung Cancer Screening Trial imply for the effectiveness of computerized tomography screening in the US population? Issa Dahabreh Harvard University NLST Nov 2, 2022 NLST-983
Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates Hormuzd Katki NCI PLCO Nov 1, 2022 PLCO-1091
Association between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of pancreatic cancer in a national prospective cohort study Yunpeng Yu Indiana University PLCO Nov 1, 2022 PLCO-1088